Opioid risk assessment in palliative medicine

Bibliography

• World Health Organization. National cancer control programmes: policies and managerial guidelines. (2nd ed.). World Health Organization, Geneva. 2002
   Google Scholar
• World Health Organization. Cancer pain relief: with a guide to opioid availability. World Health Organization, Geneva. 1996
   Google Scholar
• Ripamonti C, Bandieri E, Roila F. Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 2011;22(Suppl 6):vi69-77
   Google Scholar
• Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol 2012;13(2):e58-68
   PubMed Web of Science ®Google Scholar
• Muir JC, Scheffey C, Young HM, et al. Opioid prescribing practices before and after initiation of palliative care in outpatients. J Pain Symptom Management 2013;45(6):1107-11
   PubMed Web of Science ®Google Scholar
• Deandrea S, Montanari M, Moja L, et al. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 2008;19(12):1985-91
   Google Scholar
• Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: An update of a systematic review of undertreatment of patients with cancer. J Clin Oncol 2014;32(36):4149-54
   PubMed Web of Science ®Google Scholar
• Weiss SC, Emanuel LL, Fairclough DL, et al. Understanding the experience of pain in terminally ill patients. Lancet 2001;357(9265):1311-15
   PubMed Web of Science ®Google Scholar
• Coyle N. In their own words: Seven advanced cancer patients describe their experience with pain and the use of opioid drugs. J Pain Symptom Manage 2004;27(4):300-9
   PubMed Web of Science ®Google Scholar
• Regnard C, George R, Grogan E, et al. So, farewell then, doctrine of double effect. BMJ 2011;343:d4512
   PubMedGoogle Scholar
• Deschepper R, Laureys S, Hachimi-Idrissi S, et al. Palliative sedation: Why we should be more concerned about the risks that patients experience an uncomfortable death. Pain 2013;154(9):1505-8
   PubMed Web of Science ®Google Scholar
• Boland J, Boland E, Brooks D. Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone. Clin Med 2013;13(2):149-51
   PubMed Web of Science ®Google Scholar
• Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305(13):1315-21
   PubMed Web of Science ®Google Scholar
• Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med 2010;152(2):85-92
   PubMed Web of Science ®Google Scholar
• Gomes T, Mamdani MM, Dhalla IA, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Int Med 2011;171(7):686-91
   PubMed Web of Science ®Google Scholar
• Paulozzi LJ, Kilbourne EM, Shah NG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med 2012;13(1):87-95
   PubMed Web of Science ®Google Scholar
• Clemens KE, Quednau I, Klaschik E. Is there a higher risk of respiratory depression in opioid-naive palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Palliat Med 2008;11(2):204-16
   PubMed Web of Science ®Google Scholar
• Pasero C, McCaffery M. Pain assessment and pharmacologic management. Elsevier/Mosby, St. Louis, Mo. 2010
   Google Scholar
• Cashman J, Dolin S. Respiratory and haemodynamic effects of acute postoperative pain management: Evidence from published data. Br J Anaesth 2004;93(2):212-23
   PubMed Web of Science ®Google Scholar
• Hudgel DW, Devadatta P. Decrease in functional residual capacity during sleep in normal humans. J Appl Physiol Respir Environ Exerc Physiol 1984;57(5):1319-22
   PubMed Web of Science ®Google Scholar
• Hudgel DW, Martin RJ, Johnson B, et al. Mechanics of the respiratory system atid breathing pattern during sleep in normal humans. J Appl Physiol Respir Environ Exerc Physiol 1984;56(1):133-7
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep Medicine. International classification of sleep disorders–third edition (ICSD-3). Darien, Illinois 2014
   Google Scholar
• Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: Effects of gender. Am J Respir Crit Care Med 2001;163(3):608-13
   PubMed Web of Science ®Google Scholar
• Webster LR, Choi Y, Desai H, et al. Sleep disordered breathing and chronic opioid therapy. Pain Med 2008;9(4):425-32
   PubMed Web of Science ®Google Scholar
• Bernards CM, Knowlton SL, Schmidt DF, et al. Respiratory and sleep effects of remifentanil in volunteers with moderate obstructive sleep apnea. Anesthesiology 2009;110(1):41-9
   PubMed Web of Science ®Google Scholar
• Mogri M, Nadler J, Khan T, et al. Complex sleep apnea in patients with obstructive sleep apnea on opioids for chronic pain. Sleep Biol Rhythms 2014;12(2):127-34
   Web of Science ®Google Scholar
• Mogri M, Desai H, Webster L, et al. Hypoxemia in patients on chronic opiate therapy with and without sleep apnea. Sleep Breath 2009;13(1):49-57
   PubMed Web of Science ®Google Scholar
• Ramachandran SK, Haider N, Saran KA, et al. Life-threatening critical respiratory events: A retrospective study of postoperative patients found unresponsive during analgesic therapy. J Clin Anesth 2011;23(3):207-13
   PubMed Web of Science ®Google Scholar
• Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998;157(1):144-8
   PubMed Web of Science ®Google Scholar
• Dahan A, Overdyk F, Smith T, et al. Pharmacovigilance: A review of opioid-induced respiratory depression in chronic pain patients. Pain Physician 2013;16(2):E85-94
   PubMed Web of Science ®Google Scholar
• Rocker G, Young J, Donahue M, et al. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. CMAJ 2012;184(9):E497-504
   PubMed Web of Science ®Google Scholar
• Ekström MP, Bornefalk-Hermansson A, Abernethy AP, et al. Safety of benzodiazepines and opioids in very severe respiratory disease: National prospective study. BMJ 2014;348:g445
   Google Scholar
• Qaseem A, Snow V, Shekelle P, et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: A clinical practice guideline from the American College of Physicians. Ann Int Med 2008;148(2):141-6
   PubMed Web of Science ®Google Scholar
• Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327(7414):523-8
   PubMed Web of Science ®Google Scholar
• Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: A dose increment and pharmacovigilance study. J Pain Symptom Manage 2011;42(3):388-99
   PubMed Web of Science ®Google Scholar
• Saunders KW, Dunn KM, Merrill JO, et al. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med 2010;25(4):310-15
   PubMed Web of Science ®Google Scholar
• Fishbain DA, Cutler RB, Rosomoff HL, et al. Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review. J Pain Symptom Manage 2003;25(6):559-77
   PubMed Web of Science ®Google Scholar
• Borgeat A. Do opioids affect the ability to drive safely? J Pain Palliat Care Pharmacother 2010;24(2):167-9
   PubMedGoogle Scholar
• Cross KL. Should our hospice patients be driving? J Palliat Med 2011;14(7):804-5
   PubMed Web of Science ®Google Scholar
• Camilleri M. Opioid-induced constipation: Challenges and therapeutic opportunities. Am J Gastroenterol 2011;106(5):835-42
   PubMed Web of Science ®Google Scholar
• McMillan S, Tittle M. A descriptive study of the management of pain and pain-related side effects in a cancer center and a hospice. Hosp J 1994;10(1):89-107
   Google Scholar
• McMillan SC. Presence and severity of constipation in hospice patients with advanced cancer. Am J Hosp Palliat Care 2002;19(6):426-30
   PubMedGoogle Scholar
• Twycross RG, Harcourt JM. The use of laxatives at a palliative care centre. Palliat Med 1991;5(1):27-33
   Google Scholar
• Levine S, Shega J. What medications are effective in preventing and relieving constipation in the setting of opioid use? In: Evidence-based practice of palliative medicine. Goldstein N and Morrison R, editors. Elsevier/Saunders, Philadelphia; 2013
   Google Scholar
• Candy B, Jones L, Goodman ML, et al. Laxatives or methylnaltrexone for the management of constipation in palliative care patients. Cochrane Database Syst Rev 2011;(1):CD003448
   Google Scholar
• Bruera E. Ethical issues in palliative care research. J Palliat Care 1994;10(3):7-9
   PubMedGoogle Scholar
• Childers JW, Arnold RM. “I feel uncomfortable ‘calling a patient out’”: Educational needs of palliative medicine fellows in managing opioid misuse. J Pain Symptom Manage 2012;43(2):253-60
   PubMed Web of Science ®Google Scholar
• Bruera E, Moyano J, Seifert L, et al. The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 1995;10(8):599-603
   PubMed Web of Science ®Google Scholar
• Ward SE, Goldberg N, Miller-McCauley V, et al. Patient-related barriers to management of cancer pain. Pain 1993;52(3):319-24
   PubMed Web of Science ®Google Scholar
• Passik SD, Portenoy RK, Ricketts PL. Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis. Oncology (Williston Park) 1998;12(4):517-21
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249(6):751-7
   PubMed Web of Science ®Google Scholar
• Passik SD, Theobald DE. Managing addiction in advanced cancer patients: Why bother? J Pain Symptom Manage 2000;19(3):229-34
   PubMed Web of Science ®Google Scholar
• Scham M, Scham A. Hospices: Medical and legal considerations. Legal Med 1985:297-322
   Google Scholar
• Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med 2005;6(2):107-12
   PubMed Web of Science ®Google Scholar
• Novy DM, Lam C, Gritz ER, et al. Distinguishing features of cancer patients who smoke: Pain, symptom burden, and risk for opioid misuse. J Pain 2012;13(11):1058-67
   PubMed Web of Science ®Google Scholar
• Meltzer EC, Rybin D, Saitz R, et al. Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the current opioid misuse measure (COMM). Pain 2011;152(2):397-402
   PubMed Web of Science ®Google Scholar
• Ma JD, Horton JM, Hwang M, et al. A single-center, retrospective analysis evaluating the utilization of the opioid risk tool in opioid-treated cancer patients. J Pain Palliat Care Pharmacother 2014;28(1):4-9
   PubMedGoogle Scholar
• Moore T, Jones T, Browder J, et al. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med 2009;10(8):1426-33
   PubMed Web of Science ®Google Scholar
• Koyyalagunta D, Bruera E, Aigner C, et al. Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. Pain Med 2013;14(5):667-75
   PubMed Web of Science ®Google Scholar
• Glajchen M. Chronic pain: Treatment barriers and strategies for clinical practice. J Am Board Fam Pract 2001;14(3):211-18
   PubMedGoogle Scholar
• Childers JW, King LA, Arnold RM. Chronic pain and risk factors for opioid misuse in a palliative care clinic. Am J Hosp Palliat Care 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Ehrentraut JH, Kern KD, Long SA, et al. Opioid misuse behaviors in adolescents and young adults in a hematology/oncology setting. J Pediatr Psychol 2014;39(10):1149-60
   PubMed Web of Science ®Google Scholar
• Miaskowski C. The use of risk-management approaches to protect patients with cancer-related pain and their healthcare providers. Oncol Nurs Forum 2008;35(Suppl):20-4
   PubMedGoogle Scholar
• Spinks T, Albright HW, Feeley TW, et al. Ensuring quality cancer care. Cancer 2012;118(10):2571-82
   PubMedGoogle Scholar
• Kirsh KL, Jass C, Bennett DS, et al. Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care 2007;5(03):219-26
   PubMedGoogle Scholar
• Christo PJ, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician 2011;14(2):123-43
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Malla Y, Wargo BW, et al. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (lc/ms/ms) of urine drug testing (udt) opioids and illicit drugs in chronic pain patients. Pain Physician 2011;14(2):175-87
   PubMed Web of Science ®Google Scholar
• Passik S, Portenoy R, Ricketts P. Substance abuse issues in cancer patients. Part 2: Evaluation and treatment. Oncology 1998;12(5):729-34
   PubMed Web of Science ®Google Scholar
• Anghelescu DL, Ehrentraut JH, Faughnan LG. Opioid misuse and abuse: Risk assessment and management in patients with cancer pain. J Natl Compr Canc Netw 2013;11(8):1023-31
   PubMed Web of Science ®Google Scholar
• Koyyalagunta D, Burton AW, Toro MP, et al. Opioid abuse in cancer pain: Report of two cases and presentation of an algorithm of multidisciplinary care. Pain Physician 2011;14(4):E361-71
   PubMed Web of Science ®Google Scholar
• Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. N Engl J Med 2011;364(12):1144
   PubMed Web of Science ®Google Scholar
• Trescot A, Faynboym S. A review of the role of genetic testing in pain medicine. Pain Physician 2014;17(5):425
   PubMed Web of Science ®Google Scholar
• Klepstad P, Fladvad T, Skorpen F, et al. Influence from genetic variability on opioid use for cancer pain: A european genetic association study of 2294 cancer pain patients. Pain 2011;152(5):1139
   PubMed Web of Science ®Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10(2):113-30
   PubMed Web of Science ®Google Scholar
• Fine PG, Finnegan T, Portenoy RK. Protect your patients, protect your practice: Practical risk assessment in the structuring of opioid therapy in chronic pain. J Fam Pract 2010;59(9 suppl 2):S1-16
   PubMedGoogle Scholar
• Simone CBII, Vapiwala N, Hampshire MK, et al. Cancer patient attitudes towards analgesic utilization and pain intervention. Clin J Pain 2012;28(2):157
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cancer pain relief: Report of a WHO expert committee. World Health Organ Tech Rep Ser 1990;804:1-75
   PubMedGoogle Scholar
• Webster LR, Webster RM. Predicting aberrant behaviors in opioid treated patients: Preliminary validation of the opioid risk tool. Pain Med 2005;6(6):432-42
   PubMed Web of Science ®Google Scholar
• Akbik H, Butler SF, Budman SH, et al. Validation and clinical application of the screener and opioid assessment for patients with pain (SOAPP). J Pain Symptom Manage 2006;32(3):287-93
   PubMed Web of Science ®Google Scholar
• Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: Predicting outcomes of opioid prescribing for chronic pain. J Pain 2006;7(9):671-81
   PubMed Web of Science ®Google Scholar